The importance of NFκB1 rs4648068 and RUNX2 rs7771980 polymorphisms in bone metabolism of postmenopausal Polish women.

NFκB1 RUNX2 osteoporosis polymorphism postmenopausal women

Journal

Ginekologia polska
ISSN: 2543-6767
Titre abrégé: Ginekol Pol
Pays: Poland
ID NLM: 0374641

Informations de publication

Date de publication:
29 Apr 2021
Historique:
received: 15 06 2020
accepted: 01 12 2020
entrez: 29 4 2021
pubmed: 30 4 2021
medline: 30 4 2021
Statut: aheadofprint

Résumé

Osteoporosis is a multifactorial disease that causes a loss of bone density. However, genetic factors play an increasingly important role in its development. To thoroughly understand the molecular mechanisms, polymorphic variants of genes candidate for osteoporosis are still being sought. The aim of our study was to investigate the influence of NFκB1 gene rs4648068 (A>G) and RUNX2 gene rs7771980 (-1025T>C) polymorphisms on the risk of osteoporosis. A group of 675 postmenopausal Caucasian women (109 women with osteopenia, 333 with osteoporosis and 233 with normal T-score) were examined. The bone mineral density (BMD) at the lumbar spine (L1-L4) was measured by dual energy x-ray absorptiometry (DXA). The analysis of NFκB1 and RUNX2 polymorphisms was performed using real-time PCR method. Analysis of NFκB1 gene rs4648068 polymorphism showed that the GG genotype was slightly more frequent in the study groups compared to the control group. In the osteoporosis group, patients with the G allele in the genotype have lower bone mineral density values. For the RUNX2 rs7771980 polymorphism, in women with osteopenia we observed an increased incidence of TC heterozygotes compared to the control group (29.40% vs 24.90%, p > 0.05), and in women with osteoporosis, the TT genotype was more common (78.70% vs 73.80%, p > 0.05). No correlation was observed between the genotypes and the clinical parameters. The analysis showed no significant relationship between the genotypic distribution and the individual clinical parameters. However, it is suggested an association between the rs4648068 polymorphism of the NFκB1 gene and an increased risk of developing osteoporosis.

Identifiants

pubmed: 33914303
pii: VM/OJS/J/69242
doi: 10.5603/GP.a2021.0044
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Anna Bogacz (A)

Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland. aniabogacz23@o2.pl.
Department of Histocompatibility with Laboratory of Genetic Diagnostics, Regional Blood Center, Poznan, Poland. aniabogacz23@o2.pl.

Aleksandra Gorska (A)

Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Poznan, Poland.

Adam Kaminski (A)

Clinic of Pediatric Orthopedics, Pomeranian Medical University, Szczecin, Poland.

Marlena Wolek (M)

Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Poznan, Poland.

Hubert Wolski (H)

Division of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Division of Gynecology and Obstetrics, Podhale Multidisciplinary Hospital, Nowy Targ, Poland.

Agnieszka Seremak-Mrozikiewicz (A)

Division of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Poznan, Poland.

Jaroslaw Goracy (J)

Independent Laboratory of Invasive Cardiology, Pomeranian Medical University in Szczecin, Poland.

Boguslaw Czerny (B)

Department of Stem Cells and Regenerative Medicine, Institute of Natural Fibres and Medicinal Plants, Poznan, Poland.
Department of Pharmacology and Pharmacoeconomics, Pomeranian Medical University in Szczecin, Poland.

Classifications MeSH